Neogen Corporation

Neogen Corporation

NEOGยทNASDAQ

$8.81

-1.2%
HealthcareMedical - Diagnostics & Research

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed producers and processors; grain producers and processors; producers of cookies, crackers, candy, ice cream, and other processed foods; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segment's products are used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

At a Glance

Live Snapshot
Market Cap$1.92B
EPS-5.0300
P/E Ratio-1.75
Earnings Date07/28/2026
3Y-14.0%
5Y-32.0%
10Y+65.0%
3Y+2.0%
5Y+12.0%
10Y+62.0%
3Y-123.0%
5Y-105.0%
10Y-110.0%
NEOG

Neogen Corporation Cash Conversion Engine

NEOG ยท NASDAQ
Net Income-1.09B
Depreciation & Amortization125.67M
Stock-Based Compensation17.29M
Change in Working Capital-5.93M
Others1.07B
Capital Expenditures-104.59M
Free Cash Flow-46.35M

Cash Flow Quality Analysis

FCF Conversion Rate

4.2%

Weak cash conversion. Significant portion of earnings not converting to cashโ€”review working capital trends and capital intensity.

CapEx Intensity

179.6%

Very high capital intensity consumes most operating cash flow. Limited flexibility for dividends or debt reduction.

FCF Growth Trend

+39.1%

Strong FCF growth demonstrates improving cash generation and business momentum. Positive signal for sustainability.

Working Capital Impact

-$5.93M

Minimal working capital impact on FCF. Changes in operating assets and liabilities well-managed.

Cash Flow Quality Insight

Working capital strain: Significant cash tied up in operations. Monitor receivables collection, inventory turns, and payment terms to optimize cash conversion cycle.

Neogen Corporation Cash Flow Statement

NEOG โ€ข NASDAQ

Neogen Corporation Cash Flow StatementMay 2025May 2024May 2023May 2022May 2021May 2020May 2019May 2018May 2017May 2016May 2015May 2014May 2013May 2012May 2011May 2010May 2009May 2008May 2007May 2006
OPERATING ACTIVITIES
-1.1B
-9.4M
-22.9M
48.3M
60.9M
59.5M
60.2M
63.1M
43.8M
36.6M
33.5M
28.2M
27.2M
22.5M
22.8M
17.5M
13.9M
12.1M
9.1M
7M
125.7M
121.2M
90.5M
24.1M
21M
18.4M
17.6M
17.1M
14.7M
12.2M
10.6M
9.2M
7.4M
6.2M
5.3M
4.4M
3.9M
3.5M
2.8M
2.4M
-57.8M
-27.4M
-19.2M
-4.7M
-640K
1.6M
1.2M
-3M
-292K
1.9M
496K
-542K
287K
1.3M
2.3M
-200K
1.6M
450K
813K
485K
17.3M
13.8M
10.2M
7.2M
6.4M
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.1B
9.8M
6.7M
-2.4M
0.0
6.5M
5.5M
5M
1.5M
2.5M
2M
-1.2M
-198K
626K
-755K
1.3M
1.3M
1.4M
1.2M
912K
(26.5M)
(22.3M)
(15.5M)
(17.2M)
(15M)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
-5.9M
-72.7M
-24.2M
-4.4M
-6.6M
-62K
-20.7M
-13.1M
563K
-17.8M
-2.9M
-13.9M
-8.1M
-8.4M
-823K
4.9M
-9.6M
-9.6M
-3.8M
716K
58.2M
35.3M
41M
68M
81.1M
85.9M
63.8M
69.1M
60.3M
35.3M
43.8M
21.7M
26.6M
22.3M
28.8M
28M
11M
7.9M
10.2M
11.6M
INVESTING ACTIVITIES
-104.6M
-111.4M
-65.8M
-24.4M
-26.7M
-24.1M
-14.7M
-20.9M
-14.6M
-14.2M
-9.6M
-11.5M
-8.9M
-12.4M
-7.8M
-5.4M
-2.8M
-2.5M
-4.7M
-2.7M
(5.1M)
(108K)
(12.5M)
-38.7M
-50.8M
-13.2M
-6.4M
-891K
-34M
-42.5M
-6.6M
-39.3M
-13.3M
-4M
(0.0)
-20.3M
-11.1M
-10.1M
(0.0)
-20.7M
(0.0)
(0.0)
-12.5M
-415.9M
-792.7M
-458.3M
-437.3M
-361.4M
-162.8M
-151.6M
-105.9M
-91.7M
-82.8M
-71.6M
-60.3M
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
325K
82M
266.8M
381.8M
764.6M
406.7M
339.2M
299.8M
149.2M
147.2M
93.7M
91.2M
67M
72.3M
40.1M
0.0
0.0
0.0
0.0
6.5M
-99.2M
-29.3M
(201M)
-97.2M
-105.6M
-88.8M
-119.1M
-83.1M
-62.1M
-61.1M
-28.5M
-51.3M
-38M
-15.8M
-28M
-25.7M
-14M
-12.6M
-4.7M
-23.5M
FINANCING ACTIVITIES
2.2M
2.5M
1.2M
7.9M
34.6M
29.4M
13.9M
23.3M
21.1M
12.4M
8.6M
14.9M
9.5M
5.8M
10.3M
5.9M
2M
5.1M
15.4M
1.5M
-321K
-420K
-100M
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-10M
10M
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
-3.1M
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
-923K
(0.0)
(0.0)
-29K
-3.5M
-118K
-19.3M
-1.1M
-1.1M
0.0
0.0
0.0
3.9M
2.9M
2.5M
4.8M
3M
1.1M
1.8M
809K
564K
531K
531K
328K
-1.6M
1.9M
-118.1M
6.8M
33.5M
29.4M
13.9M
23.3M
25.1M
15.3M
11M
19.6M
12.5M
6.9M
12M
6.7M
2.6M
5.6M
6M
11.8M
CASH FLOW SUMMARY
942K
-502K
-5.2M
-8.8M
264K
-1.9M
21K
-3.4M
-898K
-294K
-984K
659K
-113K
-167K
14.2M
-8.6M
6.8M
-785K
-11.3M
1.8M
-41.6M
7.4M
118.8M
-31.1M
9.3M
24.6M
-41.4M
5.5M
22.3M
-10.8M
25.4M
-9.4M
987K
13.2M
27M
321K
6.4M
61K
215K
1.8M
170.6M
163.2M
44.5M
75.6M
66.3M
41.7M
83.1M
77.6M
55.3M
66.1M
40.7M
50M
49M
35.8M
8.8M
8.5M
2.1M
2M
1.8M
0.0
129M
170.6M
163.2M
44.5M
75.6M
66.3M
41.7M
83.1M
77.6M
55.3M
66.1M
40.7M
50M
49M
35.8M
8.8M
8.5M
2.1M
2M
1.8M
-46.4M
-76.2M
-24.7M
43.6M
54.4M
61.8M
49.2M
48.2M
45.7M
21.1M
34.2M
10.1M
17.7M
9.9M
21M
22.6M
8.1M
5.4M
5.5M
8.9M

SEC Filings

NEOG - Filing history and reports

Filing TypeFiling DatePeriod EndingFiscal YearActions
8-K

8-K 2026

N/A

April 20, 2026
April 20, 2026
2026
10-Q

10-Q 2026 Q1

Q1

April 09, 2026
February 28, 2026
2026
8-K

8-K 2026

N/A

April 09, 2026
April 09, 2026
2026
8-K

8-K 2026

N/A

March 30, 2026
March 30, 2026
2026
8-K

8-K 2026

N/A

January 08, 2026
January 08, 2026
2026
10-Q

10-Q 2025 Q4

Q4

January 08, 2026
November 30, 2025
2025
8-K

8-K 2025

N/A

October 30, 2025
October 30, 2025
2025
8-K/A

8-K/A 2025 (Amended)

N/A

October 28, 2025
August 14, 2025
2025
8-K

8-K 2025

N/A

October 27, 2025
October 23, 2025
2025
8-K/A

8-K/A 2025 (Amended)

N/A

October 27, 2025
October 23, 2025
2025
Showing 1 to 10 of 393 filings